WORLD 21/09/15 China fully vaccinates more than 1 billion people

[성기화 요셉]

China fully vaccinates more than 1 billion people

China accounts for more than a third of the 5.18 billion shots that have been administered globally

AFP, Beijing 

Published: September 16, 2021 11:57 AM GMT ▾

Trending

1

Priest attacks Duterte, Pacquiao for being pro-deathSep 17, 2021

2

Internally bleeding Indian church too weak to face challengesSep 17, 2021

3

Covid locks down two convents in the PhilippinesSep 17, 2021

4

Sri Lankan Church asks to probe monk's worry about attack Sep 17, 2021

5

Baptist pastor shot dead in MyanmarSep 20, 2021

6

People fleeing Myanmar in lurch in India’s Mizoram stateSep 17, 2021

7

Time for Indonesian Church to take ‘Laudato Si’ seriouslySep 17, 2021

8

Top Indonesian cop wants softer approach to protestsSep 17, 2021

9

Vietnamese nuns mark 75 years of indigenous orderSep 17, 2021

10

Hong Kong’s jailed Catholic media mogul gets US awardSep 17, 2021

This file photo taken on January 5, 2021 shows a medical worker displaying a syringe with the Sinovac Biotech vaccine against the COVID-19 coronavirus at a healthcare centre in Yantai in eastern China's Shandong province. (Photo: AFP)

China has fully vaccinated more than one billion people against the coronavirus -- 71 percent of its population -- official figures showed Thursday.

The country where the virus was first detected has mostly curbed the virus within its borders, but is racing to get the vast majority of its population vaccinated as a new outbreak flickers in the southeast.

"As of September 15, 2.16 billion vaccine doses have been administered nationwide," said National Health Commission spokesman Mi Feng at a press briefing.

Donate to UCA News with a small contribution of your choice

Chinese health authorities said late last month that 890 million people in China had been fully vaccinated and two billion doses administered.

The government has not publicly announced a target for vaccination coverage, but top virologist Zhong Nanshan said last month that the country is likely to have 80 percent of its population inoculated by the end of the year, reaching herd immunity.

China is currently battling an outbreak of the Delta variant in the southeastern province of Fujian that has infected almost 200 people so far in three cities, dozens of whom are schoolchildren.

The Fujian cluster is the biggest rebound in weeks and comes after the country declared the Delta variant under control, in a test of China's "zero-case" approach to the pandemic.

China reported 49 new domestic transmissions on Thursday, the vast majority in Fujian.

Authorities said the cluster's suspected patient zero was a man who had recently returned from Singapore to the city of Putian, and developed symptoms after completing a 14-day quarantine and initially testing negative for the virus.

The man's 12-year-old son and a classmate were among the first patients detected in the cluster last week, shortly after the new school term began.

Related News

-

Faulty vaccine scandal sparks outrage in China

Cambodia turns to China for Covid-19 vaccines

Macau churches to reopen after closure for Delta variant 

China reports zero local virus cases as Delta spread falls

The variant then raced through classrooms, infecting more than 36 children including 8 kindergartners, city authorities said Tuesday, in the first major school-linked spread the country has seen since the start of the pandemic.

Despite rolling out its vaccine campaign to include minors aged 12-17 in July, most young children remain unvaccinated in China, sparking fears that the latest Fujian outbreak could hit the most vulnerable people in the country disproportionately.

Authorities have rushed to quash the outbreak with targeted lockdowns, travel restrictions, mass testing and school closures before the upcoming October 1 public holiday, a week-long tourism peak.

Chinese vaccines have nearly 60 percent efficacy against the Delta strain, with antibodies rising with a booster shot, Zhong previously said.

The country is also racing to produce its own mRNA vaccine -- whose technology is believed to be more effective against the Delta variant -- with candidates by state-owned Sinopharm and domestic firm Walvax Biotechnology currently in development.